Abstract t
Endotoxinn (LPS) tolerance is characterized by a reduced capacity of monocytes to produce proinflammatoryy cytokines upon restimulation in vitro. To determine whether LPS exposuree induces a change in lymphocyte cytokine production and whether this results in a shiftt in the Thl/Th2 balance, whole blood obtained from 7 healthy subjects before and after ann i.v. injection of LPS (4 ng/kg), was stimulated in vitro with the T cell stimuli anti-CD3/CD288 or Staphylococcal Enterotoxin B. Whole blood production of Thl cytokines IFN-yy and IL-2 was markedly reduced at 3 and 6 h, while the production of Th2 cytokines IL-44 and IL-5 was not influenced or slightly increased. The IFN-y/IL-4 ratio was strongly decreasedd at 6 h. Serum obtained after LPS exposure could slightly inhibit the release of IFN-y,, while increasing IL-4 production during stimulation of blood drawn from subjects nott previously exposed to LPS. Normal serum also inhibited IFN-y production, albeit to a lesserr extent. LPS exposure influences lymphocyte cytokine production, resulting in a shift towardss a Th2 type cytokine response, an effect that in part may be mediated by soluble factorss present in serum after LPS administration in vivo.
Introduction n
Endotoxinn (lipopolysaccharide, LPS), a component of the outer cell membrane of gramnegativee bacteria, is considered to be a central mediator in the pathogenesis of gramnegativee sepsis. Intravenous injection of LPS to healthy humans not only initiates a cascade off inflammatory pathways, but also induces a temporary refractory state, generally referred too as LPS tolerance (10, 28) . LPS tolerance is characterized by decreased production of tumorr necrosis factor a (TNF), interleukin-ip (IL-lp), IL-6 and IL-10, with concurrently increasedd production of IL-1 receptor antagonist (IL-lra), upon ex vivo restimulation of wholee blood or peripheral blood mononuclear cells (PBMC's) with LPS. The same alterationss in the capacity to produce cytokines have been found in whole blood or monocytess isolated from sepsis patients (8, 13, 21, 29) or from patients after surgery (14). Therefore,, LPS tolerance can be considered an adaptive host immune response rather than a generalizedd hyporesponsiveness, which is not specific for prior exposure to LPS.
Mostt research on LPS tolerance focused on the reduced reactivity of monocytes. Only recentlyy it has become apparent that other cell types may also display a reduced responsivenesss during in vitro stimulation. Indeed, neutrophilic granulocytes isolated from patientss with sepsis, produced less IL-1 (3 and IL-8 upon ex vivo stimulation with LPS (15, 18) .. The effects of endotoxemia on the production of cytokines by T lymphocytes are unknown.. It has been reported that major surgery results in a severe defect in T cell proliferationn and cytokine secretion (6, 12) . In addition, surgical stress may induce a shift in thee T helper 1 (Thl)/ Th2 balance towards a Th2 type immune response (6, 24) . A recent studyy in mice indicated that in vivo administration of LPS may result in a reduced ability of splenocytess to produce the T cell cytokines IL-2, IL-4 and interferon-y (IFN-y) upon ex vivoo stimulation with concanavalin A (ConA), as reflected by a diminished capacity to accumulatee mRNA encoding these cytokines (5) . Therefore, in the present study we sought too determine whether LPS exposure in healthy subjects induces a change in cytokine productionn by lymphocytes, and whether this results in a shift in the Thl/ Th2 balance, as indicatedd by the production of Thl and Th2 type cytokines during in vitro whole blood stimulationn with T cell stimuli.
Materialss and methods

Studyy design
Sevenn healthy male volunteers (mean age 21, range 19-25 years) were admitted to the Clinicall Research Unit of the Academic Medical Center. Written informed consent was obtainedd from all study subjects. The study was approved by the research and ethical committeess of the Academic Medical Center. Medical history, physical and routine laboratoryy examination, chest X-ray and electrocardiogram of all volunteers were normal. Eachh volunteer received an intravenous bolus injection of Escherichia coli LPS, lot G (Unitedd States Pharmacopeia! Convention, Rockville, MD) administered over one minute in ann antecubial vein at a dose of 4 ng/kg. Heparinized blood for in vitro stimulation and FACScann analysis was obtained directly before LPS injection (t= 0 h) and at 3, 6 and 24 h thereafter.. In addition, blood was collected in vacutainer tubes and after clotting, serum was collectedd after centrifugation (10 min. at 1600 x g at 4°C) and stored at -20°C.
Wholee blood stimulation
Heparinizedd blood, diluted 1:1 in pyrogen-free RPMI 1640 (Bio Whittaker, Venders, Belgium),, was stimulated for 24 h at 37°C in the presence or absence of the T cell stimuli anti-(a)CD3/aCD288 (Central Laboratory of the Netherlands Red Cross Blood Transfusion Service,, Amsterdam, the Netherlands (CLB); final concentration 1:1000 both) or the superantigenn Staphylococcal Enterotoxin B (SEB) (Sigma, St. Louis, MO; 1 ug/ml). After thee incubation, supernatant was collected after centrifugation and stored at -20°C until assayss were performed.
InIn a separate series of experiments, serum obtained from the 7 volunteers before (normall serum) and 3 h after in vivo exposure to LPS (post-LPS serum) was pooled and subsequentlyy incubated for 24 h at 37°C with whole blood obtained from 6 other healthy donorss (who were not exposed to LPS) in the presence or absence of ocCD3/ aCD28. Wholee blood was collected aseptically using a sterile collecting system consisting of a butterflyy needle connected to a syringe (Becton Dickinson & Co, Rutherford, NJ). Anticoagulationn was obtained using endotoxin-free heparin (Leo Pharmaceutical Products B.V., Weesp,, the Netherlands; final concentration 10 U/ml). In these experiments, whole blood wass diluted 1:1 in pyrogen free RPMI containing different dilutions of pooled normal or post-LPSS serum (final concentrations 1-20 %). After the incubation, plasma was prepared byy centrifugation and stored at -20°C until assays were performed.
FACScann analysis
PBMC'ss were isolated by Ficoll-Hypaque density gradient centrifugation (Ficoll Paque, Pharmaciaa Biotech, Uppsala, Sweden) at room temperature for 20 minutes at 1000 x g. PBMC'ss were collected in the inter-phase, washed twice with PBS and resuspended in FACSS buffer (PBS supplemented with 0.01% (w/v) NaN 3 , 0.5% (w/v) BSA and 0.3 mM EDTA).. For staining, 0.5 x 10 6 cells/ tube were incubated with the following mouse monoclonall Abs: Cy-Chrome5-labeled anti-CD3 (Immunotech, Marseille, France) and phycoerythrin-labeledd anti-CD4 (Immunotech) or isotype controls (Immunotech). Lymphocytess were gated by forward and site scatter and 5,000 cells were counted.
Assays s
IFN-YY and IL-4 (both CLB; detection limit 4 and 1.2 pg/ml respectively), IL-2 (R&D Systems,, Abingdon, United Kingdom) and IL-5 (Medgenix, Fleurus, Belgium; 8.2 pg/ml) weree measured by ELISA's according to the instructions of the manufacturer. Leukocyte countss and differentials were determined in K 3 -EDTA-anticoagulated blood using flow cytometry. .
Statisticall analysis
Alll values are given as mean SE. Comparisons were done using the Wilcoxon test. P < 0.055 was considered to represent a significant difference.
Results s
Clinicall response to LPS Intravenouss injection of LPS was associated with transient influenza-like symptoms, includingg headache, nausea, myalgia and chills, starting 1-2 h after LPS administration, and lastingg no longer than 3-4 h. In addition, a rise in body temperature was recorded, peaking att 3-4 h after LPS (38.8 0.2°C; P < 0.05). 
Tablee 1. Effect of LPS administration in vivo on cell counts and differentials
Ill l Effectss of LPS on lymphocyte counts
Effectss of LPS on leukocyte counts and differentials at time points at which whole blood wass collected for in vitro stimulation are listed in Lable 1. After an initial decline, leukocyte countss strongly increased after LPS administration, and remained high until 24 h.
Lymphocytee counts strongly decreased after LPS administration with lowest cell numbers afterr 6 h, returning to baseline after 24 h. Lhis decrease in lymphocytes was associated with aa decrease in the number of CD3+/CD4+ cells with lowest cell counts at 6 h. 
Inn vitro cytokine production by whole blood after in vivo LPS injection
Sincee the number of peripheral blood Th cells changed after LPS injection, cytokine productionn was corrected for the number of CD3+/CD4+ lymphocytes present at the selectedd time points, and expressed per 10 6 CD3+/CD4+ cells. IFN-y and IL-2 were measuredd as Thl cytokines, while IL-4 and IL-5 were measured as Th2 cytokines.
Incubationn of whole blood without stimulus did not result in detectable cytokine levels.
Afterr stimulation with ocCD3/aCD28 or SEB, high levels of IFN-y and IL-2, and low levels off IL-4 and IL-5 were found (Fig. 1) . The capacity of whole blood to produce IFN-y after stimulationn with aCD3/ocCD28 or SEB was markedly reduced at 3 h and 6 h after in vivo exposuree to LPS. Also, SEB-induced IL-2 production was strongly decreased. In contrast, aCD3/aCD28-stimulatedd IL-4 production was slightly increased although this difference wass not significant The capacity to produce IL-5 after stimulation with aCD3/aCD28 and SEBB increased after LPS injection, peaking at 6 h. Too determine whether LPS exposure induced a shift in the Thl/Th2 balance, we calculated thee ratio between IFN-y. the prototypic Thl cytokine, and IL-4, the prototypic Th2 cytokine,, production at the different timepoints. The IFN-y/IL-4 ratio strongly decreased afterr restimulation in vitro with either aCD3/aCD28 or SEB, with lowest ratio at 6h after LPSS injection (Fig. 2) . 
Effectt of serum obtained after in vivo exposure to LPS on cytokine production by normall whole blood
Too study whether soluble factors present in serum play a role in the effects on Thl and Th2 cytokinee production, serum was collected before and after LPS exposure and added during stimulationn with aCD3/ccCD28 of whole blood, drawn from subjects not previously exposedd to LPS in vivo. Normal serum inhibited the production of IFN-y induced by aCD3/aCD288 in a dose-dependent manner (P < 0.05), while IL-4 production was not changedd (Fig. 3) . Compared with levels obtained after stimulation with similar concentrationss of normal serum, serum obtained 3 h after in vivo exposure to LPS slightly reducedd aCD3/aCD28-induced IFN-y production when added at a concentration of 1% (P << 0.05). In contrast, post-LPS serum at 1% and 10% increased the production aCD3/aCD28-inducedd IL-4 production compared to normal serum (both P < 0.05). The effectt of post-LPS serum on IFN-y and IL-4 production did not differ from normal serum whenn added at 20%. The IFN-y/IL-4 ratio after whole blood stimulation with ccCD3/aCD28 wass 370.5 95.9 when no serum was added. Addition of normal serum caused a dosedependentt decrease in the IFN-y/IL-4 ratio (P < 0.05) (Fig. 3) . Serum obtained at 3 h after LPSS injection caused a further decrease in the IFN-y/IL-4 ratio compared with normal serumm (P < 0.05 when added at 1%). IL-2 production was not changed by the addition of eitherr normal or post-LPS serum, while IL-5 production was influenced by normal and post-LPSS serum in a similar manner as IL-4 production (data not shown). Serumm obtained from 7 healthy subjectss directly prior to (normal serum)) and 3 h after (post-LPS serum)) an i.v. injection of LPS (4 ng/kg)) was pooled and added to wholee blood obtained from subjectss (n=6) not previously exposedd to LPS, which was then stimulatedd with aCD3/aCD28 forr 24 h at 37°C. Data (mean SE)) are expressed as percentage changee relative to incubation of wholee blood with aCD3/aCD28 onlyy (i.e. without serum added). IFN-yy concentrations after whole bloodd stimulation with ocCD3/aCD288 were 17.2 4.3 ng/ml,, IL-4 levels were 49.4 10.00 pg/ml. * P < 0.05 versus no serumm added. * indicates P < 0.05 versuss normal serum.
Discussion n LPSS tolerance is characterized by a reduced responsiveness of monocytes isolated from healthyy subjects after LPS exposure or from sepsis patients, upon restimulation in vitro. In thee present study we sought to determine whether LPS exposure in vivo induces a change in thee capacity of lymphocytes to produce cytokines, and whether this results in a shift in the Thl// Th2 balance. We found that after LPS injection into healthy subjects, stimulation of wholee blood in vitro with specific T cell stimuli resulted in a markedly decreased productionn of the Thl cytokines IFN-y and, partly, IL-2, while the production of the Th2 cytokiness IL-4 and IL-5 was not influenced or slightly increased. Consequently, the Thl/Th22 balance was shifted towards a Th2 type cytokine response. Addition of serum obtainedd after LPS exposure to normal blood could in part mimic the LPS tolerant state foundd after direct aCD3/aCD28 stimulation of post-LPS blood.
CD4++ T helper cells can be divided into Thl and Th2 cells, that can be distinguished byy the pattern of cytokine production upon ex vivo stimulation (20) . Thl cells produce cytokiness like IFN-y, IL-2 and TNF, while Th2 cells secrete IL-4, IL-5 and IL-10. In the presentt study, we chose to measure IFN-y, IL-2, IL-4 and IL-5 since, unlike TNF and IL-10,, they are produced predominantly or exclusively by lymphocytes (20) . LPS administrationn induced a strong decrease in the number of CD3+/CD4+ lymphocytes. Therefore,, the cytokine production by whole blood was expressed as nano-or picograms perr 10 6 CD3+/CD4+ lymphocytes present in blood at the selected timepoints. Hence, the decreasee in cell numbers can not explain the observed changes in cytokine production. We usedused whole blood stimulation rather than stimulation of isolated cells, since the former systemm is considered to mimic in vivo conditions best, with hormones, cytokines and other solublee factors able to influence cytokine production present (25) . Resultss of our study are consistent with data reported on lymphocyte function after majorr surgery. Surgical stress results in a decreased T cell effector function, associated with aa reduced capacity to produce Thl cytokines, and a severe defect in T cell proliferation (6, 12) .. In addition, major trauma has been reported to result in a shift towards a Th2 cytokine responsee (24) . Until recently it was thought that LPS does not have an effect on T lymphocytee function. However, a study in mice demonstrated that LPS administration resultss in activation of CD4+ T cells, as measured by the expression of T cell activation markerss (5) . Also, LPS injection was associated with a diminished capacity of splenocytes too accumulate mRNA encoding IL-2, IL-4 and IFN-y upon in vitro stimulation with ConA. Inn the present study we found that LPS exposure in vivo results in a decreased capacity of lymphocytess to produce Thl cytokines, with a shift towards a Th2 type cytokine response. Thee Thl/Th2 balance plays a critical role in the outcome of several infectious and autoimmunee diseases (22) . A Thl mediated response is known to enhance cell-mediated immunity,, while a Th2 type response in associated with humoral immunity (1). Our data suggestt that during systemic infection, a shift towards a Th2 type cytokine response occurs, whichh may result in a defect in cell-mediated immunity. In addition, since IFN-y is a major activatorr of monocyte functions (2), our data suggest that the reduced capacity of T cells to producee IFN-y may contribute to the diminished monocyte responsiveness during endotoxemiaa and sepsis. Indeed, treatment of septic patients with IFN-y has been found to restoree monocyte LPS-induced TNF production ex vivo (7).
Somee differences were seen between the effects of ctCD3/otCD28-or SEB-stimulated cytokinee production, in particular on IL-2 production. It is conceivable that differences in thee mechanisms by which aCD3/ctCD28 and SEB activate T cells contribute to this discrepancy.. Indeed, crosslinking of CD3 and CD28 results in direct T cell activation, whichh is independent of the presence of antigen-presenting cells (APC's). SEB, a product off Staphylococcus aureus, is a superantigen which requires binding to both an APC and a T celll to induce T cell stimulation. By binding to the MHC class II peptide of the APC, SEB cann bind to the V(3 region of the T cell receptor, resulting in polyclonal T cell activation (16) . .
Previouss studies have tried to elucidate the mechanisms which contribute to the developmentt of a LPS refractory state of monocytes. After LPS injection into healthy subjects,, the capacity of whole blood to produce monocyte-derived proinflammatory cytokiness diminishes strongly (28) . This effect is partly mediated by soluble mediators producedd within 2 h after LPS administration, since stimulation of normal whole blood with serumm obtained after LPS exposure, could in part mimic the LPS tolerant state (28) . It has beenn reported that septic serum inhibits TNF production by whole blood stimulated with EscherichiaEscherichia coli (26) . Also, plasma obtained from patients with meningococcal septic shock,, strongly inhibits LPS-induced activation of normal human monocytes, with an importantt role of IL-10 in the decreased monocyte responsiveness (4) . Given these data and consideringg that LPS can not influence lymphocyte function directly, we found it of interest too evaluate the role of soluble factors induced by LPS in the observed alterations in lymphocytee cytokine secretion. Addition of serum obtained after LPS exposure in vivo couldd qualitatively mimic the effects found on the production of lymphocyte-derived cytokiness after direct stimulation of post-LPS blood with T cell stimuli. Hence, these data suggestt that these changes likely occur in an indirect way, possibly via soluble factors producedd after LPS exposure. Recently, it has been described that increased expression of thee p50 subunit of NFKB is involved in the suppression of TNF production in LPS-tolerant monocytes/macrophagess (3). Which intracellular effect mediates the change in lymphocyte cytokinee production remains to be established.
Interestingly,, normal serum dose-dependently inhibited ctCD3/ctCD28-induced IFN-y production,, while not influencing IL-4 production, thus resulting in a decrease in the IFNy/IL-44 ratio. These data suggest that normal serum contains soluble factors which direct the immunee response towards a Th2 type cytokine response, and that LPS exposure increases thee concentration and/ or activity of these or other factors in serum. However, since the effectss of 20% normal and post-LPS serum on lymphocyte cytokine release were similar, thee LPS effect apparently is overruled when serum is added in higher amounts, i.e. when thee physiologically present "Thl inhibitory factors" are added in relatively high concentrations.. At present it remains speculative which serum factors may be involved in inhibitionn of a Thl cytokine response, although the IL-12p40 homodimer and the recently identifiedd IL-18 binding protein seem to be conceivable candidates (9, 17, 23) . IL-12p40 homodimerss function as an IL-12 receptor antagonist, thereby inhibiting the Thl driving cytokinee IL-12, and IL-12p40 homodimer levels increase after an LPS challenge (11). IL-188 binding protein can be considered a soluble IL-18 decoy receptor which reduces the biologicall availability of IL-18, an important cofactor for IFN-y production and IL-12-drivenn Thl development (19, 23, 27 ).
LPSS injection into normal humans alters the profile of cytokines released by activated TT cells, which is associated with a shift towards a Th2 type cytokine response. Serum obtainedd after LPS exposure could qualitatively reproduce these changes during stimulation off normal blood, suggesting that soluble factors in serum contribute to this effect. Further studiess are required to identify which soluble factors and which intracellular pathways are involvedd in LPS-induced changes in lymphocyte cytokine production.
